- Home
- / Shockwave Medical
Shockwave Medical
Stock Price
$334.8
2024-05-31
Market Capitalization
$12.6 B
2024-05-31
Revenue
$730.2 M
FY, 2023
Shockwave Medical Summary
Company Summary
- Overview
- Shockwave Medical is a company developing interventional therapy for calcified cardiovascular disease. It provides the Lithoplasty balloon dilatation catheters. The company also offers intravascular lithotripsy, a novel treatment option that allows calcium modification.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- Santa Clara, CA, US | view all locations
- Website
- http://shockwavemedical.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Isaac Zacharias, President & Chief Commercial Officer
Dan Puckett, CFO
Beaux Alexander, VP of Clinical Affairs
Operating MetricsView all
Patients Tested to Date
179
Feb, 2019
LocationsView all
2 locations detected
Santa Clara, CA HQ
United States
5403 Betsy Ross Dr
Kleve, NRW
Germany
Siemensstraße 31
Shockwave Medical Financials
Summary Financials
- Revenue (Q1, 2024)
- $218.8M
- Gross profit (Q1, 2024)
- $190.6M
- Net income (Q1, 2024)
- $55.3M
- Cash (Q1, 2024)
- $281.7M
- EBIT (Q1, 2024)
- $42.4M
- Enterprise value
- $13.0B